The validity of Lee's prognostic classification was confirmed using an independent sample. Background. As yet, no clinical or morphological prognostic classification of IgA nephropathy (IgAN ) has Conclusions. These classifications identify groups at high risk of ESRF. Therapeutic studies should focus been generally accepted. The objective of our study was to quantify the risk of developing end-stage renal on these groups. failure (ESRF ) in IgAN. Methods. We report a prospective longitudinal study of 210 patients with IgAN confirmed by biopsy Key words: end-stage renal failure; IgA nephropathy; between 1987 and 1991. Thirty-two (15.2%) patients prognostic classification were lost to follow-up. Mean follow-up after renal biopsy was 5.6 (SD=2.6) years. The variables included age, gender, illnesses prior to discovery of IgAN, clinical features at IgAN discovery, 24-h proteinuria, serum creatinine, IgA level, and antihypertensive drugs taken at the time of renal biopsy. Sixty-six renal Introduction biopsies were classified by light-microscopy according to Lee's morphological classification. The end-point IgA nephropathy (IgAN ) is the most frequent primitwas ESRF. Survival was analysed by a backward and ive glomerulonephritis [1, 2] . Despite 25 years of forward stepwise procedure using the Cox model. The research into this condition much remains unknown most accurate determination of relative risk was about its pathogenesis and therapy [3, 4] . One major obtained by assessing collinearity of the variables. problem is that the prognostic evaluation of IgAN is Results. Thirty-three patients (15.7%) (31 men) unreliable. Five studies [5] [6] [7][8][9] have examined prodeveloped ESRF. The five univariately significant vari-gnostic factors using multivariate analysis, but the ables: gender, gross haematuria, 24-h proteinuria candidate factors and their prognostic value varied (24-P), serum creatinine (SC ), and antihypertensive from one study to another [10]. These differences treatment, were candidates for multivariate analysis. are undoubtedly due to differing epidemiological The final model used SC (∏100, 100-150, approaches. All the studies were retrospective, with >150 mmol/l ), 24-P (<1, Á1 g/day) and gender cohorts constituted over 10 years [5] [6] [7][8][9]. These studies (female vs male) as independent variables (relative risk were not conclusive as they did not avoid recruitment and 95% confidence interval were 3.5 (2.1, 5.9) for SC; bias, had many missing data, and many patients were 5.1 (1.9, 13.6) for 24-P; and 3.5 (0.9, 15) for gender). lost to follow-up. Also, recommendations for the These estimates were used to construct a prog-optimal use of multivariate analyses [11][12] [13] [14] [15] were not nostic classification of ERSF for men with IgAN: always respected. stage 1 (SC∏150 mmol/l and 24-P<1 g/day), Two outlines of clinical prognostic classification stage 2 ((SC>150 mmol/l and 24-P<1 g/day) have been published [5, 6 ] , but neither has been generor (SC∏150 mmol/l and 24-PÁ1 g/day)); stage 3 ally accepted. A prognostic classification is useful, even (SC>150 mmol/l and 24-PÁ1 g/day). The ESRF-free if it cannot predict the outcome for individual patients, survival was estimated with Kaplan-Meier analysis. It because it may help evaluate the disease progression was 98.5% for stage 1, 86.6% for stage 2, 21.3% for and outcome for a group of patients. It may thus assist stage 3 (P<0.001), 7 years after histological diagnosis. clinicians to formulate appropriate management plans and identify patients at risk of chronic renal insuffiCorrespondence and offprint requests to: Dr L. Frimat, Service de ciency. We assembled a prospective, multicentre cohort Néphrologie, Hô pitaux de Brabois, F-54500 Vandoeuvre-les-Nancy, over a short inclusion time to analyse the prognosis of 
Subjects and methods
the score test. Variables that reached the 15% significance level in the univariate analysis were considered first for a Study design and follow-up backward stepwise multivariate analysis and then for a forward stepwise multivariate analysis (enter and remove Patients over 10 years old who had undergone a renal biopsy limits equal to 0.15 and 0.05 respectively). We attempted to between January 1987 and December 1991, and who had satisfy Harrell's recommendations [13] of 10 outcome events major IgA deposits in the mesangium of all the glomeruli in per independent variable. the biopsy were included in a prospective, longitudinal, The Cox model assumes that the relation between the multicentre study. Any patient suffering from Henoch-scaled variable of age, time between discovery and histoSchö nlein purpura, lupus erythematosus, or cirrhosis was logical diagnosis, systolic and diastolic blood pressure, 24-h excluded. Almost all the nephrologists and pathologists proteinuria, serum creatinine, IgA level, and the risk of practising in eastern France (20 Nephrology units) who take ESRF is logarithmically linear. To check this assumption, and examine renal biopsies took part in this study. Hence, these variables were divided into subclasses according to almost all cases of IgAN in this geographical area were empirical medians and quartiles from the sample, or common included [2] . Inclusion and follow-up clinical data were clinical cutpoints (for example Á3 g/day for 24-h procollected by the nephrologists who performed the biopsy (see teinuria). Each variable was then encoded into exclusive Appendix). The time origin was defined as the day of the classes and nested classes and the increase of b from one first renal biopsy. The observation period was extended to class to the next was studied. If the increase was regular, a December 1996. discrete variable with k categories was used. If the increase was not fairly consistent, it was recoded into two classes [12, 13, 17] .
Baseline predictor variables
The Cox model assumes that the magnitude of the risk associated with each prognostic variable remains constant Baseline predictor variables included age, gender, illnesses over time [12, 13, 17] . This assumption has been checked prior to discovery of IgAN (such as infection (upper respiratusing time-dependent covariates [12, 17] and Moreau's ory, respiratory and others infections), tonsillitis in particumethod [12, 18] . The follow-up data were divided into sublar, tonsillectomy) and clinical features at IgAN discovery classes according to empirical medians and quartiles from (gross haematuria, microscopic haematuria, proteinuria, or the sample, i.e. 2.3, 5.4 and 7.2 years. hypertension). The time between discovery and histological
We defined a score for each patient as the component of diagnosis was calculated. Systolic and diastolic blood presthe log-failure rate which does not change with time (i.e. zb sure, 24-h proteinuria, serum creatinine, and IgA level were in Cox's notation). Based on the histogram of these scores, measured at the time of renal biopsy and any antihypertensive patients were split into three stages [19] . ESRF-free survival drugs taken were recorded. Records of the baseline variables rate was plotted over time for each stage using the were complete, except for illnesses preceding IgAN for four Kaplan-Meier method. Differences in ESRF-free survival patients and IgA level in 38 patients.
between stages were tested with log-rank statistics. Since 1989, one of the pathologists (BA) has classified 66
The 66 patients graded according to Lee's classification biopsies by light-microscopy using Lee's classification [16 ] were not significantly different from the other 144 patients (I, normal without crescents/segmental lesions (sclerosis, in terms of age, gender, duration of disease before renal adhesions, necrosis); II, <50% glomeruli showing proliferabiopsy, gross haematuria, microscopic haematuria, systolic tion of mesangial cells, with or without crescents/segmental and diastolic blood pressure, 24-h proteinuria, IgA level, and lesions in <15% glomeruli; III, >50% glomeruli showing serum creatinine. Thus this graded group was treated as a proliferation of mesangial cells, with or without crescents/ representative sample of the entire cohort, using which we segmental lesions in <50% glomeruli; IV, as for III, but attempted to graphically validate Lee's classification. with crescents/segmental lesions/total glomerular sclerosis in All analyses were performed using BMDP statistical soft-50-75% glomeruli; V, as for III, but with crescents/segmental ware [20] . lesions/total glomerular sclerosis in >75% glomeruli).
Outcomes

Results
The end-point of individual follow-up was end-stage renal failure (ESRF ) requiring dialysis or renal transplantation. A total of 210 patients satisfied the inclusion criteria; Patients who did not reach the end-point were classified as 173 (82.4%) were men. The mean age was 36.2 years censored; they were lost to follow-up, died before dialysis or (median 35.1; range 10-76.7). One hundred and transplantation, or were alive at the end of the observation twenty-six patients (60%) had had an infection precedperiod. Therefore the entire cohort was included in the ing IgAN discovery, and 73 (35%) had had tonsillitis.
analysis.
Of these, 21 (10%) patients underwent tonsillectomy before biopsy and 28 (13%) after biopsy. At IgAN Statistical analysis discovery, 89 (42%) patients had gross haematuria, 168 (80%) microscopic haematuria, 160 (76%) proIn the Cox model, ezb represents the multiplicative contribu-teinuria, and 64 (31%) hypertension. The mean time tion of each covariate on the hazard function, where b is the between discovery and histological diagnosis was 45.9 unknown regression coefficient and z the observed covariate months (median 12.3; range 0.06-440) . At the time of [17] . When absence and presence of a studied factor are renal biopsy, the mean systolic blood pressure was coded z=0 and z=1 respectively, eb is the relative risk 136.1 mmHg (median 130; range 100-230), and diainduced by the studied factor on the hazard rate without this factor. The capacity of each variable to predict each outcome stolic blood pressure was 81.6 mmHg (median 80;
IgA nephropathy: prognostic classification of end-stage renal failure 2571 range 50-140). The mean 24-h proteinuria was 1.6 g three independent variables, serum creatinine, 24-h proteinuria and gender ( Table 2 , analysis 1). (median 1; range 0-12). The mean serum creatinine was 146.8 mmol/l (median 97.5; range 44-1327). The Hypertension, as indicated by antihypertensive treatment, was not entered into the model. If antihypertensmean IgA level was 3.5 g/l (median 3.2; range 0.6-9). In terms of antihypertensive treatments, 152 (72.4%) ive treatment and 24-h proteinuria had been the only two candidate variables, they would both have been patients were not treated, 29 (13.9%) were taking one drug, 23 (10.9%) two drugs, and six (2.8%) three drugs. entered into the model ( Table 2 , analysis 2). High blood pressure did not predict ESRF, once it has been Thirty-three patients (31 men) reached the endpoint, i.e. ESRF, for a total of 33 (15.7%) events. Ten corrected for serum creatinine at histological diagnosis.
This suggests that the concentration of serum creatinine patients died before ERSF. The mean follow-up time of the 167 remaining patients was 5.6 (SD=2.6) years at this time may be the link between high blood pressure and ESRF. after the histological diagnosis. Thirty-two patients were lost to follow-up 2.5 (SD=1.9) years after renal Age, adjusted for blood pressure, did not predict ESRF, suggesting that high blood pressure could be biopsy. These 32 patients had an average age of 27.7 (SD=11.9) years at histological diagnosis and had a the intervening variable in the link between age and ESRF. mean serum creatinine of 88 (SD=23.5) mmol/l.
The results of the univariate analysis are shown in Figure 1 shows the histogram of the scores, calculated using the estimated regression coefficients of Table 1 . The underlying assumption of log linearity was checked only for serum creatinine, divided into serum creatinine, 24-h proteinuria and gender in the analysis 1 ( Table 2) . A high score indicates an elevated three classes (∏100, 100/150, >150 mmol/l ) and for systolic blood pressure, divided into three classes risk of ESRF. The relative risk of ESRF was 3.5 times higher for men than women. Consequently these data (∏120, 120/150, >150 mmHg). Other continuous variables were divided into two classes.
were used to define a clinical classification system of ESRF risk for men with IgAN: Hypertension at discovery, systolic and diastolic blood pressure and the antihypertensive treatment were stage 1 (serum creatinine ∏150 mmol/l and 24-h all highly correlated. Proteinuria at discovery and 24-h proteinuria <1 g); proteinuria at histological diagnosis were also closely stage 2 ((serum creatinine >150 mmol/l and correlated. Thus the quantitative risk estimated for 24-h proteinuria <1 g) or (serum creatinine each variable may be imprecise in multivariate ana-∏150 mmol/l and 24-h proteinuria Á1 g)); lyses [13] .
stage 3 (serum creatinine >150 mmol/l and 24-h After the backward stepwise analysis, only gender, proteinuria Á1 g). gross haematuria, 24-h proteinuria, serum creatinine and antihypertensive treatment were included in the The probability of ESRF-free survival for men was 98.5% for stage 1, 86.6% for stage 2, and 21.3% for forward multivariate analysis. The model yields stage 3 (P<0.001) 7 years after histological diagnosis exceeds 150-200 mmol/l is still difficult to measure in ( Figure 2 ). As only two women had ESRF, we did renal disease. The impaired renal function may remain not develop a classification system for women. stable for a long time and then suddenly deteriorate, Thirteen (19.6%, 13 men) of the 66 patients classified leading to ESRF within a few months. While the exact according to Lee had ESRF after a mean follow-up date of ESRF is easier to determine, taking ESRF as period of 4.3 (SD: 2.4) years. Figure 3 shows the the end-point in a slow progressive disease like IgAN graphical validation of Lee's classification on these would underestimate the number of unfavourable patients (P<0.001).
events when follow-up is short. Nevertheless, like most authors [5, 6, 8] , we have used ESRF as the end-point. Some results [9] are difficult to explain, because of Discussion the many missing data (18%), the small number of events (<10%), the lack of information on the number of variables included in the final model and the value It is difficult to assess the prognosis of IgAN because of relative risk. This study identifies renal function at of the very long time between histological diagnosis last follow-up, expressed as the serum urea concentraand renal death [14] . The use of chronic renal insuffition, as a risk factor for ESRF. Incorporating informaciency as an end-point would overestimate the survival time, because the exact time at which serum creatinine tion collected during the follow-up period into the Fig. 2 . Kidney survival for men according to the stages derived from the Cox model. SC, serum creatinine; 24-P, 24-h proteinuria at renal biopsy. After 6 years of follow-up, the number of men at risk is indicated in parentheses. analysis could bias the results of an analysis toward more common in these patients. However, this difference seems to be due to age rather than IgAN. The the correct qualitative conclusion about the direction of an association [15] . present study suggests that the effect of age on renal function is due to the higher blood pressure of older The four other retrospective studies published to date [5] [6] [7] [8] all indicated that severe proteinuria was the subjects. Thus, we did not include age in the multivariate analysis to avoid minimizing the effect on prognosis main variable affecting prognosis. When it was included in the variables used in the regression, the of hypertension.
Accurate estimation of relative risk, with acceptable presence of renal insufficiency at diagnosis [6, 8] was also associated with an unfavourable prognosis. Our confidence intervals, depends directly on the methods used. A prospective study such as this has several results are consistent with this, as a model with these two variables fits our data. Other variables, such as advantages, including a complete data set at inclusion, a representative sample of all the various clinical forms the absence of gross haematuria [6 ] , initial hypertension [6, 7] , and HLA B 35 antigen [7] have been of the disorder and few cases lost to follow-up.
For IgAN, the constancy of the risk over time, an considered as indicating a poor prognosis. The results of our study indicate that high blood pressure may important assumption of the Cox model, have been considered to be uncertain [7] . We used two statistical account for the increase in serum creatinine at histological diagnosis. This elevated serum creatinine methods [17, 18] and the agreement between the results indicates that the effect on prognosis of 24-h proappears to be a more powerful prognostic factor for ESRF than high blood pressure.
teinuria, serum creatinine, and gender were constant throughout the study. In our study, 31 (17.9%) men vs 2 (5.4%) women developed ESRF. We found male gender to be an
The overall estimates of relative risk from serum creatinine at diagnosis, 24-h proteinuria at histological independent predictor of ESRF in the multiple Cox's regression analysis, in contrast with results from earlier diagnosis and gender appear to be even closer, as the confidence intervals were small. Three distinct groups multivariate studies [5] [6] [7] [8] [9] [10] . But this is consistent with two univariate studies [16, 21] , in which respectively were identified on the basis of severity. Stage 1 contained men (46% of the total ) with virtually no risk of 16.1% and 15% men vs 4.1% and 7% women respectively developed ESRF. These results are also consistent developing ESRF within 8 years. There was 1 in 5 chance of developing ESRF within 8 years in stage 2 with those of a recent epidemiological survey of primary glomerular diseases (PGD) in a French region (36% of all the men), while in stage 3 the male patient (18%) had almost a 1 in 4 chance of developing ESRF which showed that male gender was a risk factor for poor renal prognosis of PGD [1] .
within 1 year and a greater than 2 in 3 chance of developing ESRF within 5 years. Although the develThe statistical association between the potential prognostic factors means that the results of univariate opment of ESRF differs greatly between patients with IgAN, the progression of IgAN is often described as analysis should be interpreted with caution. Only certain variables found to be significant in univariate being uniform, in terms of the yearly decrease in glomerular filtration rate [3] , or by the percentage of analysis should be selected for multivariate analysis to obtain a good estimate of relative risk. The published patients developing renal failure per year of follow-up [4, 10] . Our group of male patients could be divided studies have not always fulfilled this criterion. In some cases multivariate analyses were performed with 11 or into at least three groups, each with a different rate of disease progression. This classification requires validaeven 18 variables [5, 7] . These studies, which retain all the variables as candidates to enter the model give tion by other independent studies, but it does identify clinical indicators of prognosis at 5 years not previously interesting results, but are subject to errors due to collinearity [13] . Somewhat surprisingly, renal function published.
Except in one study [23] , each prognostic [5, 7, 8, 16 ] at diagnosis was not a variable selected in two studies [5, 7] . Consequently, in these studies, the prognostic and therapeutic [24] [25] [26] study defines histological progression differently. There is no international consensus value of the histological data must be analysed with caution, as there is a correlation between the degree for a morphological classification. Lee [16 ] found that glomerular lesions were all that was required for proof renal insufficiency and the severity of histological lesions. We included only the five variables that gnosis, whereas others also included tubulointerstitial [5, 7, 8] and vascular lesions [7] . Our data show that appeared to summarize all the information, and which were not correlated (gender, gross haematuria, 24-h Lee's classification [16 ] is valid, at least for a short follow-up period. It is easy to use and accurately proteinuria, antihypertensive treatment, and serum creatinine) in our stepwise analysis to limit these sources predicts prognosis for cases of IgAN. However, it may be necessary to regroup certain grades ( Figure 3 ). of bias.
In a preliminary study [22] , we showed that subjects Various trials of potential IgAN therapies have been conducted [23] [24] [25] [26] . Most treatments have not proved over the age of 50 were more commonly hypertensive at the onset of IgAN. At histological diagnosis, systolic effective in controlled trials. Recent trials have been more encouraging despite conflicting results [24, 25] . blood pressure was significantly higher, but not diastolic blood pressure in these subjects over age 50. The Many features of these studies should be reviewed [3] , particularly the lack of stratification for proteinuria glomerular and tubulointerstitial lesions were no more severe in the older patients and only endarteritis was and renal function. This study provides a clinical
